skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines mosunetuzumabQuestion & answer

mosunetuzumab · Medicine question

Is mosunetuzumab recommended during pregnancy?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Mosunetuzumab (Lunsumio) is not recommended during pregnancy or in women of childbearing potential not using contraception.

Sources for this answer

Lunsumio 1 mg and 30 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated 16 June 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about mosunetuzumab

How long is effective contraception recommended after the last mosunetuzumab infusion?Is breastfeeding recommended during mosunetuzumab treatment?Are human data available on the effects of mosunetuzumab on fertility?Has fatal haemophagocytic lymphohistiocytosis been reported with mosunetuzumab?What signs of tumour flare have been reported with mosunetuzumab?Which patients receiving mosunetuzumab need particular monitoring for tumour lysis syndrome?

mosunetuzumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the mosunetuzumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX